dengue hemorrhagic fever


Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia.
Related to dengue hemorrhagic fever: Dengue Shock Syndrome

den·gue

(den'gā),
A disease of many tropic and subtropic regions that can occur epidemically; caused by dengue virus, a member of the family Flaviviridae. There are four antigenic types, and they are transmitted by a mosquito of the genus Aedes (usually A. aegypti, but frequently A. albopictus). Four grades of severity are recognized: grade I, fever and constitutional symptoms; grade II, grade I with spontaneous bleeding (of skin, gums, or gastrointestinal tract); grade III, grade II with agitation and circulatory failure; grade IV, profound shock.
[Sp. corruption of "dandy" fever]

den·gue

, dengue hemorrhagic fever , dengue fever (deng'ē, hem'ŏr-aj'ik fē'vĕr)
A disease of tropic and subtropic regions, caused by dengue virus and transmitted by a mosquito of the genus Aedes. Four grades of severity are recognized: grade I, fever and constitutional symptoms; grade II, spontaneous bleeding (of skin, gums, or gastrointestinal tract); grade III, agitation and circulatory failure; and grade IV, profound shock.
[Sp. corruption of "dandy" fever]

dengue hemorrhagic fever

Abbreviation: DHF
A grave sequela of dengue, marked by fever, headache, myalgia, arthralgias, rash, spontaneous bleeding, increased blood vessel permeability to proteins, and low platelet counts (< 100,000/mm3).
See also: fever
References in periodicals archive ?
In: Proceedings of International Conference on Dengue Hemorrhagic Fever, Kuala Lumpur, Malaysia, pp.
The patient never developed a severe thrombocytopenia or a laboratory-confirmed coagulopathy, possibly suggesting that changes in vascular permeability, platelet dysfunction, or other factors may be responsible for bleeding seen in dengue hemorrhagic fever.
Clinical and laboratory characteristics and risk factors for fatality in elderly patients with dengue hemorrhagic fever.
Dengue hemorrhagic fever with special emphasis on immunopathogenesis.
Dengue hemorrhagic fever may lead to intracranial bleeding because it lowers the platelet count.
Currently, there are no approved vaccines nor drugs available to treat either dengue fever or its potentially fatal complication, dengue hemorrhagic fever.
Those bitten by the mosquito can get dengue fever and those already infected once if infected again are prone to higher risk of getting dengue hemorrhagic fever.
Dengue and dengue hemorrhagic fever have been described as potential public health threats for residents of the US mainland (14).
Food and Drug Administration today allowed marketing of the first test to help diagnose people with signs and symptoms of dengue fever or dengue hemorrhagic fever, a leading cause of illness and death in the tropics and subtropics.
Silent spread of dengue and dengue hemorrhagic fever to Coimbatore and Erode districts in Tamil Nadu, India 1998: need for effective surveillance to monitor and control the disease.
Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF) are the most important vector-borne viral diseases in the World, and are prevalent in the Tropics.
In Australia, Aedes aegypti (Diptera: Culicidae) is primarily responsible for the biological transmission of dengue which manifests in four serotypes capable of causing dengue fever, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).